Our partner in Tunisia
Tunisia is one of the beneficiaries of the EU-funded EU4Monitoring Drugs II (EU4MD) project, which has been developed by the EMCDDA as part of its ongoing commitment to strengthening cooperation and sharing expertise with countries in the European Neighbourhood Policy (ENP) area.
News
Events, meetings and visits
- Bursaries offered for Lisbon Addictions 2024 to EMCDDA international cooperation partners
- International cooperation partners participate in EMCDDA-CEPOL training course on 'Drug crime and markets: strategic analysis’
- EU4MD II bursaries for 2023 European Drugs Summer School
- EMCDDA releases new findings on drug markets in the eastern and southern European Neighbourhood Policy regions
- 2022 Reitox week kicks off with a focus on young people
- News from EU4Monitoring Drugs, an EMCDDA technical cooperation project
Events
Events, meetings and visits
- EU4MD Early Warning System meeting (09.06.2022, )
- Facility surveys in EU4MD partner countries using EFSQ: data collection, analysis and reporting (22.04.2021, Online)
- 9th Extended Reitox network meeting (24.11.2020, Online)
- Virtual event on lessons learned from the impact of COVID-19 on the drug situation in Europe (30.06.2020, )
- Seminar on the EU drug monitoring system, the EMCDDA and the perspectives for cooperation with ENP partner countries (14.10.2010 to 15.10.2010, Brussels, Belgium)
- ENPI–EMCDDA Final Conference (29.06.2016, Lisbon, Portugal)
Publications
Publications related to this partner
This timeline allows you to explore a timeline highlighting some of the EU4Monitoring Drugs (EU4MD) project's achievements. As part of its ongoing commitment to strengthening cooperation and sharing expertise, EMCDDA developed the EU4Monitoring Drugs (EU4MD) project, funded by the
This report presents an analysis of the drug markets in the European Neighbourhood Policy-South region covering Algeria, Egypt, Israel, Jordan, Lebanon, Libya, Morocco, Palestine (*), Syria and Tunisia.
Since the beginning of 2020, the world has been experiencing an unprecedented public health emergency caused by the coronavirus disease (COVID-19) pandemic, which has led to progressive introduction of social distancing and other control measures by national governments.
Since the beginning of 2020, the world has been experiencing an unprecedented public health emergency caused by the coronavirus disease (COVID-19) pandemic, which has led to the progressive introduction of social distancing and other control measures by national governments.
This 2020 EMCDDA update on drug-related infectious diseases aims to provide a comprehensive overview of the current situation with regard to the epidemiological picture of drug-related infectious diseases in Europe up to January 2020, while highlighting some of the current innovative responses to
Follow the timeline and take a walk through some of the key moments in the EMCDDA's 25 years of international cooperation.
Contact information
National Bureau of Drugs at the Ministry of Health